Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz said Medicare’s solvency could be extended through drug-price reforms, fraud reduction and technology, including artificial intelligence. In a Sunday interview on CBS News’ "Face the Nation" that aired Aug. 23, 2026, Oz said CMS cut $42 billion in Medicare fraud during the previous year and claimed the trust fund "will last twice as long" if fraud is eliminated. He identified the proposed Great American Health Act, which would codify most-favored-nation drug pricing, as the administration’s plan. Oz said 17 pharmaceutical companies representing 85% of the drug sector had joined the pricing effort, eligible Medicare beneficiaries could obtain some GLP-1 medications for $50 a month compared with more than $1,000 previously, and drug prices fell 3.1% year over year in July, the fastest decline in 63 years. He also cited expanded access to medical records, an 800-company health-technology pledge and broader anti-fraud measures. Medicare’s Part A Hospital Insurance trust fund is projected to be depleted in 2033, with incoming revenue covering about 89% of scheduled expenses; Part B spending is projected to rise 8.5% annually through 2030 and Part D spending 9.4% annually. Oz also defended parental choice and state flexibility on vaccination policy while acknowledging that the MMR vaccine is not lethal.